Late-Breaking abstract submission period is now closed.
At ENDO 2018, you can expect leaders in endocrine practice and hormone research to share their latest breakthroughs that advance science and shape the future of patient care. By submitting your research for presentation at ENDO, you are not only helping to facilitate that exchange of information, you also gain valuable feedback from peers while fostering relationships for potential new partners.
By submitting your research for presentation at ENDO, you will not only have the chance to get your research in front of an engaged audience, but all accepted abstracts will also be published in Endocrine Reviews. Endocrine Reviews is ranked 4th of 138 journals in the category of Endocrinology & Metabolism with an impact factor of 15.745.
The media look to ENDO to discover the latest groundbreaking research and treatments. News articles highlighting ENDO 2017 reached nearly 2 billion unique visitors on online news sites and nearly 447,000 print readers. Stories about the meeting appeared in top-tier outlets, including The Wall Street Journal, Yahoo! Beauty, Reuters news wire service, Men’s Health magazine, International Business Times, Health magazine, London newspaper The Daily Telegraph, and STAT News, a health news site run by the owners of The Boston Globe.